Saniona AB (SANION):企業の財務・戦略的SWOT分析

◆英語タイトル:Saniona AB (SANION) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH433007FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Saniona AB (Saniona) formerly Aniona, is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which is used to treat obesity and type 2 diabetes; tesomet, a fix-dosed combination of tesofensine and metoprolol for the treatment of type 2 diabetes and prader-willi syndrome; and NS2359, a triple monoamine reuptake inhibitor, which is used to treat cocaine addiction. It also develops CAD-1883, a program for treatment of ataxia and essential tremors. The company conducts research on three classes of ion channels including GABAA receptors, nicotinic acetylcholine receptors and potassium channels. Saniona is headquartered in Ballerup, Denmark.

Saniona AB Key Recent Developments

Jan 07,2021: Saniona to present at three upcoming investor conferences
Dec 21,2020: Saniona appoints Chief Legal Officer and Chief Technical Operations Officer to its executive team
Nov 30,2020: Saniona publishes its interim report for the third quarter 2020
Aug 27,2020: Saniona publishes its interim report for the second quarter 2020
Apr 27,2020: Saniona appoints Rudolf Baumgartner, M.D., as Chief Medical Officer and Head of Clinical Development

This comprehensive SWOT profile of Saniona AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Saniona AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Saniona AB – Key Information
Saniona AB – Overview
Saniona AB – Key Employees
Saniona AB – Key Employee Biographies
Saniona AB – Key Operational Heads
Saniona AB – Major Products and Services
Saniona AB – History
Saniona AB – Company Statement
Saniona AB – Locations And Subsidiaries
Saniona AB
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Saniona AB – Business Description
Saniona AB – Corporate Strategy
Saniona AB – SWOT Analysis
SWOT Analysis – Overview
Saniona AB – Strengths
Saniona AB – Weaknesses
Saniona AB – Opportunities
Saniona AB – Threats
Saniona AB – Key Competitors

Section 3 – Company Financial Performance Charts

Saniona AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Saniona AB, Key Information
Saniona AB, Key Ratios
Saniona AB, Share Data
Saniona AB, Major Products and Services
Saniona AB, History
Saniona AB, Key Employees
Saniona AB, Key Employee Biographies
Saniona AB, Key Operational Heads
Saniona AB, Other Locations
Saniona AB, Subsidiaries
Saniona AB, Key Competitors
Saniona AB, SWOT Analysis
Saniona AB, Ratios based on current share price
Saniona AB, Annual Ratios
Saniona AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Saniona AB (SANION):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportu …
  • Ivoclar Vivadent AG:医療機器:M&Aディール及び事業提携情報
    Summary Ivoclar Vivadent AG (Ivoclar Vivadent) is an international dental products providing company. It manufactures material systems for high quality dental applications. The company’s products include impression materials, adhesives, temporary materials, restorative materials, all-ceramics, lutin …
  • Boston-Power, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Boston-Power, Inc. (Boston-Power) is a developer and manufacturer of lithium-ion battery and pack technologies. The company provides rechargeable lithium-ion cells under two brands, namely, Sonata and Swing. Its Sonata product range finds application in portable power and notebook computer m …
  • Arkray Inc:企業の製品パイプライン分析2018
    Summary Arkray Inc (Arkray), formerly KDK Corp is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis applications. Its products comprise automatic glycohemoglobin analyzer for diabetes, automated analy …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • FirstRand Private Bank:企業の戦略・SWOT・財務情報
    FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report Summary FirstRand Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Harris Corp (HRS)-医療機器分野:企業M&A・提携分析
    Summary Harris Corp (Harris) is a communications and information technology company that offers communications products, services and systems, and network solutions. The company offers tactical and land mobile radio systems, IT services, clinically integrated solutions, managed services, government …
  • Daniel Thwaites Plc:戦略・SWOT・企業財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Reach Subsea ASA (REACH):石油・ガス:M&Aディール及び事業提携情報
    Summary Reach Subsea ASA (Reach) provides engineering consultancy services and advanced remotely-operated underwater vessels (ROV) to the oil industry. The company also offers inspection, maintenance and repair, survey, construction support and decommissioning services. Reach offers multi-support ve …
  • MDI Achieve Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDI Achieve Inc (MDI), formerly MDI Technologies Inc is a technology company that designs, develops and commercializes financial and clinical management solutions. The company offers MatrixCare software solutions helps in clinical and resident management, analytics management, financial mana …
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Egdon Resources Plc (EDR):石油・ガス:M&Aディール及び事業提携情報
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Tulip Diagnostics (P) Ltd-医療機器分野:企業M&A・提携分析
    Summary Tulip Diagnostics (P) Ltd (Tulip Diagnostics), a subsidiary of Tulip Group is a diagnostic company that manufactures and markets in vitro diagnostic reagents and kits for the medical markets. The company provides assay systems for immunohaematology, hematology, rheumatology, infectious disea …
  • Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Centauri Therapeutics Ltd (Centauri Therapeutics) is a biotechnology company that discovers and develops novel molecules for life threatening diseases. The company uses alphamer technology to develop anti-infective therapeutics. Its alphamer technology is based on programmable immunity in wh …
  • Pioneer Energy Services Corp (PESX):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PESX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mission Pharmacal Company:企業の戦略・SWOT・財務情報
    Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report Summary Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • GATT Technologies BV:製品パイプライン分析
    Summary GATT Technologies BV (GATT Technologies) is a medical technology company, which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆